The recently approved CD20 inhibitor Briumvi (ublituximab-xiiy) has received a permanent insurance reimbursement code that will simplify claims submissions…
Articles by Andrea Lobo, PhD
Owen Mumford‘s Aidaptus auto-injector, which lets a wide range of under-the-skin medications to be administered, has won a Red…
Pipeline Therapeutics is collaborating with a branch of Janssen Pharmaceuticals to advance PIPE-307, a potential oral treatment of…
A three-month yoga program was significantly better than physical therapy at improving quality of life in people with multiple…
Cariloop has teamed up with Walgreens to provide support services at select neurology-specialty pharmacies to people with multiple…
EBViously announced that it has developed a candidate vaccine against the Epstein-Barr virus and plans to bring it into…
Early treatment with Mavenclad (cladribine) or monoclonal antibodies is more likely to control symptoms in people with highly active…
Smoking and exposure to secondhand smoke are both associated with significantly faster disease progression in people with multiple sclerosis…
Fujirebio has launched two fully automated laboratory tests to measure levels of the neurofilament light chain (NfL) protein, a…
People who drink black and green tea, coffee, and nonalcoholic beer may be significantly less likely to develop multiple…
Note: This story was updated March 29, 2023, to correct that cognitive function was assessed via questions about memory and…
Adherence to a high-quality diet may help alleviate symptoms of depression in people with multiple sclerosis (MS), a…
Infection with the virus that causes COVID-19 significantly accelerates neurological disability in people with multiple sclerosis (MS), at least…
Aiming to promote equitable access to multiple sclerosis (MS) treatments worldwide, an international MS alliance is asking that three disease-modifying therapies…
MS Australia is funding a study by researchers at Curtin University into how diet might affect multiple sclerosis (MS)…
Following a Mediterranean diet may reduce the risk of cognitive problems, including with memory and thinking skills, in people with…
Long-term use of Zeposia (ozanimod) did not adversely affect the heart of relapsing multiple sclerosis (MS) patients treated for one…
FSD Pharma will soon launch a first-in-human trial testing Lucid-21-302, known as Lucid-MS — its novel chemical treatment for…
Ocrevus (ocrelizumab) is a safe and effective treatment for patients under 18 with highly active relapsing-remitting multiple sclerosis…
The tiny sacs of cellular content that are released by oligodendrocytes — the myelin-producing cells of the brain and spinal…
Quanterix Corporation‘s laboratory test designed to measure blood levels of neurofilament light chain (NfL) has been validated by the…
The European Investment Bank has entered a financial agreement with Numares Health to support further development of a fully…